1. A. Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone.

   1. (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
   2. (2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.
   3. (3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.
   4. (4) Not more than two and five-tenths milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.
   5. (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.
   6. (6) Not more than five-tenths milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

2. B. Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers.

   1. (1) Pyrovalerone.
   2. (2) Pseudoephedrine as a drug that includes any compound, mixture, or preparation that contains any detectable quantity of pseudoephedrine, its salts or its optical isomers, or salts of its optical isomers. Pursuant to 30-31-10.C the following substances are excluded from schedule V controlled substances: pseudoephedrine products in liquid form including liquid filled gel caps and pseudoephedrine products already classified as dangerous drugs.

3. C. Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

   1. (1) Lacosamide [(R)-2acetoamido-N-benzyl-3-methoxy-propionamide];
   2. (2) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid];
   3. (3) Ezogabine [N-[2-amino-4-(4-flurobenzylamino-phenyl]-carbamic acid ethyl ester];
   4. (4) Brivaracetam;
   5. (5) Cenobamate;
   6. (6) Lasmiditan;
   7. (7) Ganaxolone

[16.19.20.69 NMAC - Rp 16.19.20.69 NMAC, 6/26/2018; A, 12/17/2019, A, 12/15/2020; A, 9/14/2021; A, 6/13/2023]